Literature DB >> 11122126

Meisoindigo for the treatment of chronic myelogenous leukaemia.

Z Xiao, L Qian, B Liu, Y Hao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11122126     DOI： 10.1046/j.1365-2141.2000.02357.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  Nanoscale isoindigo-carriers: self-assembly and tunable properties.

Authors:  Tatiana N Pashirova; Andrei V Bogdanov; Lenar I Musin; Julia K Voronina; Irek R Nizameev; Marsil K Kadirov; Vladimir F Mironov; Lucia Ya Zakharova; Shamil K Latypov; Oleg G Sinyashin
Journal:  Beilstein J Nanotechnol       Date:  2017-02-01       Impact factor: 3.649

2.  [The impact of meisoindigo on apoptosis and proliferation of SET2 cell line by JAK-STAT pathway].

Authors:  C L Lyu; J Q Liu; M Chen; B Chen; Z J Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.